Labels & Safety Sheets Contact Us Worldwide Operations

Enlist E3 Soybeans Successfully Complete FDA Consultation

Third Enlist Trait to Complete FDA Review for Food and Feed Safety

Wednesday, December 18, 2013 12:00 pm EST

Dateline:

INDIANAPOLIS & WEST POINT, Iowa

Public Company Information:

NYSE:
DOW
"We are committed to bringing farmers this important innovation so they can take back their fields from the weeds and enable their crops to reach their full yield potential."

INDIANAPOLIS & WEST POINT, Iowa--(BUSINESS WIRE)--Dow AgroSciences LLC, a wholly-owned subsidiary of The Dow Chemical Company (NYSE: DOW), and MS Technologies announced today that the U.S. Food and Drug Administration (FDA) has completed its consultation for Enlist E3™ soybeans. The agency has no further questions based on submitted data that concluded Enlist E3 soybeans are not different in composition, safety, and other relevant parameters from soybean-derived food and feed currently on the market. This advanced technology is part of the Enlist™ Weed Control System that combines innovative traits, herbicides, and stewardship to deliver weed control that farmers need now while sustaining beneficial farming practices.

“This past cropping season has shown that weed control challenges are getting worse, and farmers need new solutions. This regulatory consultation for Enlist E3 soybeans illustrates the strong foundation of science upon which Enlist is based,” said Joe Vertin, global business leader, Enlist Weed Control System, Dow AgroSciences. “We are committed to bringing farmers this important innovation so they can take back their fields from the weeds and enable their crops to reach their full yield potential.”

The Enlist E3 soybean event includes, for the first time, three herbicide-tolerant genes stacked together as part of a single genetic event in the soybean genome. These genes provide tolerance to Dow AgroSciences’ new 2,4-D product, glyphosate, and glufosinate. A product offering of the Enlist system, Enlist E3™ soybeans will be brought to market in high-yielding varieties, widely available in multiple brands for farmers who want improved weed control and high yields. The innovative product is being developed through a collaboration between MS Technologies and Dow AgroSciences.

The FDA consultation is a voluntary step as part of the overall federal deregulation process, which also entails a separate scientific review by the U.S. Department of Agriculture (USDA). The FDA finished its consultation regarding Enlist corn and Enlist soybeans in 2011. The USDA is currently assessing the Enlist corn and soybean traits and is conducting an Environmental Impact Statement as part of the review process.

About Dow AgroSciences

Dow AgroSciences, based in Indianapolis, Indiana, USA, develops leading-edge crop protection and plant biotechnology solutions to meet the challenges of the growing world. Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $6.4 billion in 2012. Learn more at www.dowagro.com. Follow Dow AgroSciences on Facebook, Twitter, and YouTube or subscribe to our News Release RSS Feed.

About M.S. Technologies

MS Technologies LLC is a leading trait, technology and soybean genetics provider. MS Technologies LLC features a portfolio of in-house traits, including a variety of herbicide-tolerant and insect-resistant traits, as well as wide access to other traits and technologies through collaborative agreements with other parties. Follow MS Technologies on Facebook, Twitter or learn more at www.mstechseed.com.

®™Trademark of The Dow Chemical Company (“Dow”) or an affiliated company of Dow. Regulatory approvals are pending for the Enlist™ herbicide solution and crops containing Enlist herbicide tolerance traits. The information presented here is not an offer for sale. Always read and follow label directions. ©2013 Dow AgroSciences LLC

Enlist E3 soybeans are being jointly developed by Dow AgroSciences and MS Technologies.

Contact:

Dow AgroSciences
Kenda Resler Friend, 317-337-4743
kresler@dow.com